# Similasan AG – FDA Inspection, Apr 4, 2023

Source: https://www.keypedia.com/records/fda_inspections/similasan-ag/d03916c3-5fac-4fb3-a45e-302e5b3ce40f
Source feed: FDA_Inspections

> FDA inspection 1204144 of Similasan AG, April 04, 2023. Classification: Official Action Indicated (OAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204144
- Company Name: Similasan AG
- Inspection Date: 2023-04-04
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0
- Enforcement Type: WARNING_LETTER

## Related Documents

- [FDA Inspection 1313406 - 2026-04-27](https://www.keypedia.com/records/fda_inspections/similasan-ag/001769e1-a17a-4bce-b22f-63417f904cc9)
- FDA Inspection 1028938 - 2017-09-18
- FDA Inspection 937801 - 2015-07-23
- FDA Inspection 851899 - 2013-09-13
- FDA Inspection 727380 - 2011-05-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/david-a-oluwo/209d60bd-27d8-487b-8249-1c6e44fcc317)
- [Freddy Ortiz Colon](https://www.keypedia.com/people/freddy-ortiz-colon/10993029-31ff-44ec-b5c7-75c5ed827e7b)
- [FDA Associated Person](https://www.keypedia.com/people/lisa-shin/13c87687-fe3d-41a5-8973-42be901a5b0c)

Company: https://www.keypedia.com/companies/similasan-ag/c9b97bc2-9876-49bf-9b34-57cf8c5717e8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
